2-aminothiazole compounds useful as aspartyl protease inhibitors

Details for Australian Patent Application No. 2005230878 (hide)

Owner Merck & Co., Inc.

Inventors Olsen, David B.; Holloway, M. Katharine; Stachel, Shawn J.; Espeseth, Amy S.; Hazuda, Daria J.; Coburn, Craig A.

Agent Spruson & Ferguson

Pub. Number AU-A-2005230878

PCT Pub. Number WO2005/097767

Priority 60/557,769 30.03.04 US; 60/591,386 27.07.04 US

Filing date 25 March 2005

Wipo publication date 20 October 2005

International Classifications

C07D 277/60 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097767 Priority application(s): WO2005/097767

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230881-Histamine H3 receptor agents, preparation and therapeutic uses

2005230872-Method of exchanging anions of tetraalkylammonium salts